MedPath

The neurobiological basis of bias and disengagement; Two neurotransmitter mechanisms implicated in visual spatial attention.

Withdrawn
Conditions
Geen aandoening
geneesmiddelen worden gebruikt om selectief aandachtssystemen te inhiberen dmv noradrenergisch dan wel cholinergisch antagonisme
Neurobiology of (visuospatial) attention
Registration Number
NL-OMON33564
Lead Sponsor
niversiteit Utrecht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Withdrawn
Sex
Not specified
Target Recruitment
48
Inclusion Criteria

Passing the physical/medical evaluation (in which cardiovascular functioning and blood pressure is evaluated) is a prerequisite.

Exclusion Criteria

Diagnosis of psychopathology.
Current drug use
Low blood pressure.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Behavioural measures<br /><br><br /><br>In the VSC paradigm: the validity effect in ms (RT valid cued target - RT<br /><br>invalid cued target).<br /><br>A larger validity effect reflects either more bias, or less disengagement.<br /><br><br /><br>In the stop task paradigm: the stop signal reaction time (SSRT); SSRT reflects<br /><br>inhibition and related disengagement.<br /><br><br /><br>Neurophysiological (ERP) endparameters in the VSC:<br /><br><br /><br>1) Parietal cue ERP components (ADAN + LDAP), related to bias.<br /><br>2) P1 valid cued target ERP, related to bias.<br /><br>3) LPD invalidly cued target ERP, related to disengagement.<br /><br><br /><br>Neurophysiological (ERP) endparameters in the stop task:<br /><br><br /><br>1) N2 stop signal ERP, related to disengagement.<br /><br>2) LPD stop signal ERP, related to disengagement.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>not applicable</p><br>
© Copyright 2025. All Rights Reserved by MedPath